Sponsor of the Day:
Jerkmate
https://www.statnews.com/pharmalot/2026/04/27/lilly-deal-intellia-crispr-treatment-for-rare-disease/
Pharmalittle: Lilly buying Ajax, Intellia reports HAE CRISPR results | STAT
Apr 27, 2026 - A pill for hair loss successfully spurred hair growth in a late-stage trial amid a surge of investor enthusiasm for such products
results statpharmalittlelillybuyingajax
https://www.statnews.com/2026/01/12/american-cardiovascular-health-new-study-shows-mixed-results/
U.S. cardiovascular scorecard: What's behind the mixed results | STAT
mixed resultscardiovascularscorecardbehindstat
https://www.statnews.com/2026/03/19/eli-lilly-retatrutide-in-vivo-cart-readout-newsletter/
Readout Newsletter: Eli Lilly’s 'triple-G' drug delivers striking results | STAT
Mar 19, 2026 - Today's biotech news roundup includes new Phase 3 results on Lilly's experimental obesity drug retatrutide.
readout newslettertriple gresults statelidrug